Entity
  • New England Biolabs

    Created in 1974


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    9,662 34,040
  • Activities

  • Technologies

  • Entity types

  • Location

    240 County Rd, Ipswich, MA 01938, USA

    Ipswich

    United States of America

  • Employees

    Scale: 501-1000

    Estimated: 771

  • Engaged catalyst

    16
    0 0
  • Added in Motherbase

    2 years, 2 months ago
Description
  • Value proposition

    be INSPIRED, drive DISCOVERY, stay GENUINE

    Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and subsidiaries located in Australia, Canada, China, France, Germany, Japan, New Zealand, Singapore, South Korea and the UK. For more information about New England Biolabs visit www.neb.com.

    We welcome you to our Linkedin community and we ask that you please follow our community guidelines, you can find them here: http://nebiolabs.com/community

    Visit us on Youtube for protocol and product videos: youtube.com/nebiolabs
    Follow us on Twitter: twitter.com/#!/nebiolabs

  • Reagents For the Life Sciences Industry | NEB

    NEB is a leader in the discovery and development of molecular biology reagents. Restriction enzymes, polymerases, competent cells,sample prep for NGS, and more.

  • https://www.neb.com/
Catalyst interactions
Catalyst TypeTweets Articles
Atlanpole Biotherapies
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

18 Jul 2024


PMT - pôle des microtechniques
PMT - pôle des microtechniques
Public business cluster, French Cluster, Civic and Social Organizations
PMT - pôle des microtechniques
Public business cluster, French Cluster, Civic and Social Organizations
Other

26 Sep 2023


Bayer
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Other

13 Jul 2021


Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

26 Apr 2023


BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

9 Apr 2025


USAID Competitive Economy Project
USAID Competitive Economy Project
Startup accelerator & VC, Business Consulting and Services
USAID Competitive Economy Project
Startup accelerator & VC, Business Consulting and Services
Other

13 Jul 2021


Merck Group
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Other

30 Mar 2022


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

1 Mar 2021


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

31 Jul 2015


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Other

24 Sep 2021


Social network dynamics
Similar entities
BETA
Loading...
Loading...